Applied Pharmaceutical Science, Inc. (APS) is a leading company focus on frontier innovative drug research. APS aims to explore life science research, innovate precise cancer therapy, and to seek new hope for cancer patients around the world with breakthrough cancer therapies.
Applied Pharmaceutical Science, Inc. (APS) is a leading cancer precision therapy company. APS focuses on developing unmet genetic driver cancer therapies by deep understanding of cancer genetics, protein structure and function, synthetic medicinal chemistry, experiment and computation integrated verification technology, and has developed efficient de novo innovation ability based on advanced instruments for research and development. APS aims to revolutionize the treatment of disease and provide revolutionary targeted cancer therapies.
John Z Zhu, Ph.D.
Chief Executive Officer-North America
Jun Zhong, Ph.D.
R&D and Chemistry VP
Vice President , Clinical Operation
Scientific Advisory Board
Alexander Drilon, MD
Memorial Sloan Kettering Cancer Center
Vivek Subbiah, MD
University of Texas MD Anderson Cancer Center